The role of bisphosphonate type, local concentration and acidic milieu in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw

2013 ◽  
Vol 42 (10) ◽  
pp. 1189
Author(s):  
S. Otto ◽  
J. Schwager ◽  
M. Schieker ◽  
M. Ehrenfeld ◽  
C. Pautke
2014 ◽  
Vol 2014 ◽  
pp. 1-7 ◽  
Author(s):  
A. M. Hinson ◽  
C. W. Smith ◽  
E. R. Siegel ◽  
B. C. Stack

The role of infection in the etiology of bisphosphonate-related osteonecrosis of the jaw (BRONJ) is poorly understood. Large-scale epidemiological descriptions of the histology and microbiology of BRONJ are not found in the literature. Herein, we present a systematic review of BRONJ histology and microbiology (including demographics, immunocompromised associations, clinical signs and symptoms, disease severity, antibiotic and surgical treatments, and recovery status) validating that infection should still be considered a prime component in the multifactorial disease.


2010 ◽  
Vol 68 (11) ◽  
pp. 2837-2845 ◽  
Author(s):  
Sven Otto ◽  
Christoph Pautke ◽  
Christine Opelz ◽  
Ines Westphal ◽  
Inga Drosse ◽  
...  

Nutrients ◽  
2021 ◽  
Vol 13 (2) ◽  
pp. 561
Author(s):  
Luca Dalle Carbonare ◽  
Monica Mottes ◽  
Maria Teresa Valenti

Osteonecrosis of the jaw (ONJ) is a severe clinical condition characterized mostly but not exclusively by an area of exposed bone in the mandible and/or maxilla that typically does not heal over a period of 6–8 weeks. The diagnosis is first of all clinical, but an imaging feedback such as Magnetic Resonance is essential to confirm clinical suspicions. In the last few decades, medication-related osteonecrosis of the jaw (MRONJ) has been widely discussed. From the first case reported in 2003, many case series and reviews have appeared in the scientific literature. Almost all papers concerning this topic conclude that bisphosphonates (BPs) can induce this severe clinical condition, particularly in cancer patients. Nevertheless, the exact mechanism by which amino-BPs would be responsible for ONJ is still debatable. Recent findings suggest a possible alternative explanation for BPs role in this pattern. In the present work we discuss how a condition of osteomalacia and low vitamin D levels might be determinant factors.


2018 ◽  
Author(s):  
Janne Hakkarainen ◽  
Iolanda Ialongo ◽  
Shamil Maksyutov ◽  
David Crisp

Abstract. NASA's carbon dioxide mission, Orbiting Carbon Observatory-2, has been operating for three full years (2015–2017). Here, we provide a global (60° S–60° N) view of the XCO2 anomalies along with their annual variations and seasonal patterns. We show that the XCO2 anomaly patterns are robust and consistent from year-to-year. We compare these anomalies to fluxes from anthropogenic, biospheric and biomass burning and to model-simulated local concentration enhancements. We find that, despite the simplicity of the method, the anomalies describe the spatio-temporal variability of XCO2 (including anthropogenic emissions and seasonal variability related to vegetation and biomass burning) consistently with more complex model-based approaches. We see, for example, that positive anomalies correspond to fossil fuel combustion over the major industrial areas (e.g., China, eastern USA, central Europe, India, and the Highveld region in South Africa), shown as large positive XCO2 enhancements in the model simulations. Also, we find corresponding positive anomalies and fluxes over biomass burning areas during different fire seasons. On the other hand, the largest negative anomalies correspond to the growing season in the northern middle latitudes, characterized by negative XCO2 enhancements from simulations and high SIF values (indicating the occurrence of photosynthesis). Finally, we show how XCO2 anomalies facilitate the detection of anthropogenic signatures for several local scale case studies, both in the Northern and Southern Hemisphere. The results demonstrate the potential of satellite-based XCO2 observations for understanding the role of man-made and natural contributions to the atmospheric CO2 levels.


Author(s):  
Antonia Marcianò ◽  
Gian Marco Guzzo ◽  
Matteo Peditto ◽  
Antonio Picone ◽  
Giacomo Oteri

The purpose of the present study was to estimate the prevalence of cyclin-dependent kinase (CDK) 4/6 inhibitors use among cancer patients from the medication-related osteonecrosis of the jaw (MRONJ) cohort of the University of Messina. We retrospectively reviewed the records of all patients with either intravenous bisphosphonates or denosumab-related MRONJ reported in the electronic health records of the Unit of Oral Surgery, School of Dentistry, University of Messina between the first quarter of 2018 and the first quarter 2020 to identify eligible patients. We observed six cases of MRONJ associated with CDK4/6 inhibitors concomitantly with intravenous bisphosphonates and/or denosumab in breast cancer patients. The CDK4/6 inhibitors registered were palbociclib (n = 5) and abemaciclib (n = 1). Data of cancer patients diagnosed with MRONJ in the same period (n = 10) were extracted for comparison. The comparative assessment with this group of patients showed a similar distribution of MRONJ stage ranged and clinical course after treatment. The degree of risk for osteonecrosis in patients taking these new classes of drugs is uncertain but warrants awareness and close monitoring. The role of premedication dental evaluation as a prevention strategy has been acknowledged for cancer patients about to initiate intravenous bisphosphonates and/or denosumab for treatment of bone metastasis, but additional attention should be paid to whom are assuming CDK4/6 inhibitors because of their oral adverse events.


2017 ◽  
Vol 96 (5) ◽  
pp. 539-546 ◽  
Author(s):  
L.H. He ◽  
E. Xiao ◽  
J.G. An ◽  
Y. He ◽  
S. Chen ◽  
...  

Treatment of bisphosphonate-related osteonecrosis of the jaw (BRONJ) has posed significant challenges to maxillofacial surgeons because of the poor repair of BRONJ bone defects. Moreover, the pathological mechanisms remain unclear. Bone marrow stromal cells (BMSCs) play key roles during bone repair and bone regeneration. However, the activities of BMSCs derived from BRONJ lesions and the BRONJ lesion boundary, as well as the roles of BMSCs in BRONJ defect repair, are poorly defined. In this study, we found that BMSCs from the central area of the osteonecrotic BRONJ region (center-BRONJ BMSCs) and the peripheral area at the recommended debridement boundary (peri-BRONJ BMSCs) had decreased proliferative ability, self-renewal capacity, and multidifferentiation capacities compared with control BMSCs. Osteoclast-inducing ability was also impaired in BRONJ BMSCs. All of these results suggested that the decreased activities of BRONJ BMSCs, even the BMSCs derived from the BRONJ lesion boundary, might be an important factor leading to insufficient bone repair of BRONJ lesions. This study offers early stage evidence for the use of marrow stromal cells in the treatment of BRONJ.


2013 ◽  
Vol 38 (1) ◽  
pp. 40-43 ◽  
Author(s):  
Jonathan K. Joshi ◽  
George M. Kushner ◽  
Geetika Bhatt ◽  
Aashish D. Bhatt ◽  
Ali Cahid Civelek

Sign in / Sign up

Export Citation Format

Share Document